Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1-3 Positive Lymph Nodes?
about
Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.The Challenge of Integrating Radiotherapy in the Multimodal Treatment of Breast Cancer.DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancer.
P2860
Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1-3 Positive Lymph Nodes?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Should Postmastectomy Radiothe ...... with 1-3 Positive Lymph Nodes?
@ast
Should Postmastectomy Radiothe ...... with 1-3 Positive Lymph Nodes?
@en
type
label
Should Postmastectomy Radiothe ...... with 1-3 Positive Lymph Nodes?
@ast
Should Postmastectomy Radiothe ...... with 1-3 Positive Lymph Nodes?
@en
prefLabel
Should Postmastectomy Radiothe ...... with 1-3 Positive Lymph Nodes?
@ast
Should Postmastectomy Radiothe ...... with 1-3 Positive Lymph Nodes?
@en
P2093
P2860
P356
P1433
P1476
Should Postmastectomy Radiothe ...... with 1-3 Positive Lymph Nodes?
@en
P2093
Birgitte V Offersen
Hans-Jürgen Brodersen
Jens Overgaard
Marie Overgaard
Mette M Nielsen
P2860
P304
P356
10.1159/000333250
P577
2011-10-13T00:00:00Z